不同浓度柯萨奇病毒B组3型感染幼龄大鼠动物模型的研究OA北大核心
Tissue and immune pathology in young-rat models of coxsackievirus B3-infection in relation to virus concentration
目的 利用不同浓度柯萨奇病毒B组 3 型(Coxsackievirus B3,CVB3)感染幼龄SD大鼠,探究病毒在大鼠组织分布、免疫应答以及炎症因子的反应,有助于揭示病毒感染的免疫病理,为药物筛选和疗效评价提供实验依据.方法 7 日龄SD大鼠经腹腔注射不同剂量的CVB3(TCID50 为 10-3.34/100 μL),分别于造模第 4、8 天采用流式细胞检测全血中淋巴细胞亚群比例(CD4+、CD8+),利用实时荧光定量聚合酶链反应(qRT-PCR)检测心脏、肝、脾、脑、肾、胃肠道组织 CVB3 载量,采用大鼠 ELISA 试剂盒检测组织中 TNF-α、IFN-γ水平,并采用苏木素-伊红(HE)染色观察组织形态学变化.结果 不同剂量的CVB3 可引起幼龄大鼠出现不同程度的腹泻,且体质量下降;CVB3 主要分布于胃、小肠、大肠组织及粪便,其中在大肠及粪便中载量最高;与正常组比较,原液组(TCID50=10-3.34/100 μL)幼龄大鼠全血中CD8+T比例增加和CD4+/CD8+比值减少(P<0.05,P<0.01),大肠组织中TNF-α高表达和IFN-γ低表达(P<0.05,P<0.01),病理组织观察可见大肠组织黏膜下层水肿及炎症细胞浸润,而 10-1 组、10-2 组、10-3 组幼龄大鼠全血中淋巴细胞亚群比例、TNF-α、IFN-γ含量及组织形态学均无统计学意义(P>0.05).结论 以不同剂量的CVB3 诱导幼龄SD大鼠感染模型,其中原液攻毒CVB3(TCID50=10-3.34/100 μL)可引起幼龄大鼠大肠组织病理损伤、病毒大量复制可引起炎性因子水平及免疫细胞失调,提示CVB3 病毒对幼龄大鼠具有独特的致病机制,为开发抗CVB3 病毒感染药物评价策略提供理论基础.
Objective Using different concentrations of Coxsackievirus B3(CVB3)to infect young SD rats.To investigate the distribution of coxsackievirus B3(CVB3)in rat tissues and the immune response and inflammatory factors,to clarify the immunopathological mechanism of viral infection and provide an experimental basis for drug screening and efficacy evaluation.Methods Young SD rats(7 days old)were injected intraperitoneally with different doses of CVB3(TCID50=10-3.34/100 μL)and the proportions of lymphocyte subsets(CD4+,CD8+)in whole blood at days 4 and 8 were detected by flow cytometry.The CVB3 loads in the heart,liver,spleen,brain,kidney,and gastrointestinal tissues were detected by real-time fluorescence quantitative polymerase chain reaction,TNF-α and IFN-γ levels were detected by enzyme-linked immunosorbent assay,and histomorphologic changes were observed by hematoxylin and eosin staining.Results Different doses of CVB3 caused different degrees of diarrhea and decreased body mass in young rats.CVB3 was mainly distributed in the stomach,small intestine,large intestine,and stools,with the highest load in the large intestine and stools.The stock solution group(TCID50=10-3.34/100 μL)increased the proportion of CD8+T cells in the whole blood in young rats and decreased the CD4+/CD8+ratio(P<0.05,P<0.01).Compared with the nomal group high TNF-α and low IFN-γ expression were observed in the large intestine of young rats in the concentrate group(P<0.05,P<0.01),and submucosal edema and inflammatory cell infiltration were observed in the large intestine(cecum and rectum).There were no significant differences in the proportion of lymphocyte subsets,TNF-α and IFN-γ levels,and morphological changes in whole blood of young rats in the group 10-1,10-2,and 10-3(P>0.05).Conclusions Different doses of CVB3 can induce infections in young SD rats.CVB3(TCID50=10-3.34/100 μL)causes pathological changes in the large intestine(cecum and rectum)in young rats,and high virus replication can increase levels of inflammatory factors and cause an imbalance of immune cells.CVB3 may have a unique pathogenic mechanism in young rats,providing a theoretical basis for developing evaluation strategies for drugs against CVB3 virus infections.
张卓;刘学武;陈相池;肖洒;杨柳;姜德建;彭冬冬
湖南普瑞玛药物研究中心有限公司,长沙 410329||新药药效与安全性评价湖南省重点实验室,长沙 410329湖南普瑞玛药物研究中心有限公司,长沙 410329||新药药效与安全性评价湖南省重点实验室,长沙 410329湖南普瑞玛药物研究中心有限公司,长沙 410329||新药药效与安全性评价湖南省重点实验室,长沙 410329湖南普瑞玛药物研究中心有限公司,长沙 410329||新药药效与安全性评价湖南省重点实验室,长沙 410329湖南普瑞玛药物研究中心有限公司,长沙 410329||新药药效与安全性评价湖南省重点实验室,长沙 410329湖南普瑞玛药物研究中心有限公司,长沙 410329||新药药效与安全性评价湖南省重点实验室,长沙 410329湖南普瑞玛药物研究中心有限公司,长沙 410329||新药药效与安全性评价湖南省重点实验室,长沙 410329
生物科学
CVB3幼龄SD大鼠组织分布免疫病理
CVB3young SD ratstissue distributionimmunopathology
《中国实验动物学报》 2025 (7)
1032-1042,11
湖南普瑞玛药物非临床研究创新创业团队(2021).Funded by Hunan Prima Drug Non-Clinical Research Innovation and Entrepreneurship Team(2021).
评论